EXOSENS SAS (EXENS.PA) Forecast, Price Target & Analyst Ratings
EPA:EXENS • FR001400Q9V2
67 EUR
-0.9 (-1.33%)
Last: Mar 13, 2026, 04:51 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for EXOSENS SAS (EXENS.PA).
Forecast Snapshot
Consensus Price Target
€54.59
-18.52% Downside
Next Earnings Forecast
Release DateApr 27, 2026
ChartMill Buy Consensus
80.00%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
€54.59
Upside
-18.52%
From current price of €67.00 to mean target of €54.59, Based on 19 analyst forecasts
Low
€37.37
Median
€55.59
High
€66.15
Price Target Revisions
1 Month
4.90%
3 Months
10.35%
Price Target Summary
19 Wall Street analysts provided a forecast for the next 12 months for EXENS.PA. The average price target is 54.59 EUR. This implies a price decrease of -18.52% is expected in the next year compared to the current price of 67.
The average price target has been revised upward by 10.35% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
80.00%
EXENS.PA was analyzed by 19 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about EXENS.PA.
In the previous month the buy percentage consensus was at a similar level.
EXENS.PA was analyzed by 19 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-12-12 | Berenberg | Maintains | Buy -> Buy |
Next Earnings Forecast Details
Next Earnings Details
Release DateApr 27, 2026
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 200.752M 20.81% | 291.819M 45.36% | 394.076M 35.04% | 476.75M 20.98% | 551.8M 15.74% | 626.27M 13.50% | 706.82M 12.86% | 790.24M 11.80% | 879.21M 11.26% | 826.96M -5.94% | 876.54M 6.00% | 929.12M 6.00% | |
| EBITDA YoY % growth | 49.672M 148.50% | 80.53M 62.12% | 108.932M 35.27% | 146.78M 34.74% | 175.98M 19.89% | 205.2M 16.60% | 236.62M 15.31% | 281.23M 18.85% | 321.18M 14.21% | N/A | N/A | N/A | |
| EBIT YoY % growth | 29.126M 125.46% | 49.598M 70.29% | 72.044M 45.26% | 114.23M 58.56% | 131.72M 15.31% | 153.78M 16.75% | 158.02M 2.76% | 241.68M 52.94% | 277.21M 14.70% | N/A | N/A | N/A | |
| Operating Margin | 14.51% | 17.00% | 18.28% | 23.96% | 23.87% | 24.55% | 22.36% | 30.58% | 31.53% | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | 1.49 50.07% | 1.94 30.76% | 2.29 17.95% | 2.69 17.35% | 3.32 23.24% | 3.83 15.53% | N/A | N/A | N/A |
All data in EUR
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in EUR
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
32.28%
EPS Next 5 Year
27.33%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
15.74%
Revenue Next 5 Year
14.36%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
35.41%
EBIT Next 5 Year
27.75%
EXOSENS SAS / EXENS.PA Forecast FAQ
Can you provide the average price target for EXOSENS SAS stock?
19 analysts have analysed EXENS.PA and the average price target is 54.59 EUR. This implies a price decrease of -18.52% is expected in the next year compared to the current price of 67.
What is the next earnings date for EXENS stock?
EXOSENS SAS (EXENS.PA) will report earnings on 2026-04-27.
What is the consensus rating for EXENS stock?
The consensus rating for EXOSENS SAS (EXENS.PA) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.